Langlois, Michel

Telomere length and cardiovascular risk factors in a middle‐aged population free of overt cardiovascular disease

Bekaert, S., De Meyer, T., Rietzschel, E. R., De Buyzere, M. L., De Bacquer, D., Langlois, M., Segers, P., Cooman, L., Van Damme, P., Cassiman, P., et al. (2007) · Aging Cell

Telomeres, Telomerase, and SenescenceCardiovascular Health and Disease Prevention

Cited by 348

Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 281

The Role of Nutraceuticals in Statin Intolerant Patients

Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology

Lipoproteins and Cardiovascular HealthNatural Products and Biological Research

Cited by 272

Iron status and the outcome of HIV infection: an overview

Gordeuk, V. R., Delanghe, J. R., Langlois, M. R., & Boelaert, J. R. (2001) · Journal of Clinical Virology

Iron Metabolism and DisordersHIV Research and Treatment

Cited by 124

Haptoglobin polymorphism, iron metabolism and mortality in HIV infection

Delanghe, J. R., Langlois, M. R., Boelaert, J. R., Van Acker, J., Van Wanzeele, F., van der Groen, G., Hemmer, R., Verhofstede, C., De Buyzere, M., De Bacquer, D., et al. (1998) · AIDS

HIV Research and TreatmentIron Metabolism and Disorders

Cited by 3